User:Advancescience/sandbox

= ==Anna S.F. Lok== = Anna S.F. Lok MD, FRCP is an internationally renowned hepatologist who has advanced the treatment and science of hepatitis B and C globally. She has authored hundreds of peer-reviewed articles on liver disease, co-wrote the American Association for the Study of Liver Diseases (AASLD) guidelines for hepatitis B, and will become the AASLD President in 2017. As the Chair of the Hepatitis B Research Network (HBRN), she is advancing the epidemiology and natural history of hepatitis B in the US and globally.

Anything here is above the first section. Not in table of contents.

Early life and education
Growing up in Hong Kong, Anna S.F. Lok was the first physician in her family. During her medical residency, she "fell in love with hepatology" while working with K.C. Lam and Rud Schmid and pursued a two year fellowship at the Royal Free Hospital in London, headed by Dame Sheila Sherlock.

Education and Credentialing:
M.B.B.S., 1977, University of Hong Kong M.D., 1991, University of Hong Kong F.R.C.P., 1981, United Kingdom

Residency: 1978-1981, Queen Mary Hospital

Fellowship: Hepatology, 1983, Royal Free Hospital, London, U.K.

Certification: 1981, F.R.C.P. (U.K)

Career
When Lok entered the hepatitis B field in the 1980's, hepatitis B was known as a DNA virus that caused chronic hepatitis and cirrhosis, however, there were no approved therapies. With promising US results of interferon therapy in 4 patients, Lok personally oversaw a clinical study of interferon dosing, reporting that thrice weekly interferon injections were as effective as daily injections in suppressing hepatitis B DNA.

Research Interests: Viral hepatitis, pathogenesis, natural history, and treatment of chronic hepatitis B and chronic hepatitis C, and prevention and treatment of recurrent hepatitis B and hepatitis C post liver transplantation

Clinical Interests: Hepatology: liver diseases, viral hepatitis – hepatitis B and hepatitis C, liver transplantation, and cirrhosis

Professor, Department of Internal Medicine, University of Michigan, Ann Arbor

Alice Lohrman Andrews Research Professor in Hepatology

Director, Clinical Hepatology

Associate Chair for Clinical Research, Department of Internal Medicine